September 2023
171 articles-
Sep 26 · 01:36Biotechnology Daily
Janssen's newly merged infectious disease and vaccine unit sees significant pipeline cuts
-
Sep 26 · 01:34Biotechnology Daily
Vir's shares crater as influenza mAB flames out in 'disappointing' phase 2 result
-
Sep 26 · 01:33Biotechnology Daily
J&J professes 'voracious' appetite for medtech M&A following Abiomed megadeal
-
Sep 26 · 01:32Biotechnology Daily
Congress considers easing regulations on air transport of donated organs
-
Sep 26 · 01:30Bio Business News
Eliem Therapeutics shuts down final drug program 5 months after major layoffs
-
Sep 26 · 01:29Bio Business News
Ipsen still out of regulatory luck as European Commission rejects rare disease drug
-
Sep 26 · 01:27Bio Business News
LimmaTech regains a shigella shot from GSK and a new CEO from CureVac
-
Sep 26 · 01:26Bio Business News
Sanofi pays $125M to go after undruggable inflammatory target with Recludix's preclinical program
-
Sep 25 · 00:49Biotechnology Daily
FDA clearance opens up MeMed's bacteria-versus-virus blood test to the point of care
-
Sep 25 · 00:46Biotechnology Daily
Medtronic recalls thousands of implantable defibrillators that may deliver less-powerful shocks
-
Sep 25 · 00:44Biotechnology Daily
Signant Health snaps up DSG to expand decentralized trial offerings
-
Sep 25 · 00:43Biotechnology Daily
Pfizer spies cardiovascular potential in Riparian preclinical licensing agreement
-
Sep 25 · 00:41Bio Business News
Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
-
Sep 25 · 00:34Bio Business News
NAMSA buys German CRO Clinical Research Institute for undisclosed price
-
Sep 25 · 00:32Bio Business News
FibroGen's cost-cutting search spurs 104 layoffs while ImmuneID also restructures
-
Sep 25 · 00:31Bio Business News
9 Meters calls it quits after measuring options, reports just $150K in cash
-
Sep 22 · 02:06Biotechnology Daily
Faron's latest data snapshot suggests antibody has potential as leukemia combo treatment
-
Sep 22 · 02:02Biotechnology Daily
Integrated Biosciences' optogenetics platform illuminates aging pathways in cells
-
Sep 22 · 02:00Biotechnology Daily
J&J's Abiomed receives Class I recall label over potential Impella collisions with TAVR implants
-
Sep 22 · 01:56Biotechnology Daily
Beckman Coulter, Fujirebio partner on gold rush for Alzheimer's blood tests
-
Sep 22 · 01:53Bio Business News
Masimo plans to shave $300M from full-year revenue forecast after possible 20% drop in Q2
-
Sep 22 · 01:49Bio Business News
Can biotechs be 'catfished'? AIM ImmunoTech hits back at online identity thief
-
Sep 22 · 01:47Bio Business News
AstraZeneca bails on failed Pieris asthma asset, forcing the biotech to restructure, lay off 70% of staff
-
Sep 22 · 01:45Bio Business News
Neurogene inks Neoleukin reverse merger, raises $95M to fund gene therapies to clinical data drops